{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:11:06Z","timestamp":1789398666273,"version":"build-2803163510"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,22]]},"DOI":"10.7759\/cureus.90724","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T09:41:27Z","timestamp":1755855687000},"source":"Crossref","is-referenced-by-count":2,"title":["Global Research Trends in Bladder Cancer Biomarkers: A Bibliometric Analysis"],"prefix":"10.7759","author":[{"given":"Alvin Tung","family":"Yong Zong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei Kang","family":"Yap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Global Cancer Observatory. Cancer today. (2024). Accessed: December 4, 2024: https:\/\/gco.iarc.fr\/."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410x.1990.tb14997.x","article-title":"Urinary infection following out-patient flexible cystoscopy","volume":"66","author":"Clark KR","year":"1990","unstructured":"Clark KR, Higgs MJ. Urinary infection following out-patient flexible cystoscopy. Br J Urol. 1990, 66:503-5. 10.1111\/j.1464-410x.1990.tb14997.x","journal-title":"Br J Urol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-4096.2001.01899.x","article-title":"The community-based morbidity of flexible cystoscopy","volume":"89","author":"Burke DM","year":"2002","unstructured":"Burke DM, Shackley DC, O'Reilly PH. The community-based morbidity of flexible cystoscopy. BJU Int. 2002, 89:347-9. 10.1046\/j.1464-4096.2001.01899.x","journal-title":"BJU Int"},{"key":"ref4","article-title":"Diagnosing and staging bladder cancer","year":"2015","unstructured":"Diagnosing and staging bladder cancer. Bladder Cancer. Diagnosis and Management: NICE Guideline. National Institute for Health and Care Excellence, London, UK; 2015."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000003846","article-title":"Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline: 2024 amendment","volume":"211","author":"Holzbeierlein JM","year":"2024","unstructured":"Holzbeierlein JM, Bixler BR, Buckley DI, et al.. Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline: 2024 amendment. J Urol. 2024, 211:533-8. 10.1097\/JU.0000000000003846","journal-title":"J Urol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2014.06.008","article-title":"Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer","volume":"33","author":"Yafi FA","year":"2015","unstructured":"Yafi FA, Brimo F, Steinberg J, Aprikian AG, Tanguay S, Kassouf W. Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer. Urol Oncol. 2015, 33:66.e25-31. 10.1016\/j.urolonc.2014.06.008","journal-title":"Urol Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2021.10.003","article-title":"Diagnostic accuracy of novel urinary biomarker tests in non-muscle-invasive bladder cancer: a systematic review and network meta-analysis","volume":"4","author":"Laukhtina E","year":"2021","unstructured":"Laukhtina E, Shim SR, Mori K, et al.. Diagnostic accuracy of novel urinary biomarker tests in non-muscle-invasive bladder cancer: a systematic review and network meta-analysis. Eur Urol Oncol. 2021, 4:927-42. 10.1016\/j.euo.2021.10.003","journal-title":"Eur Urol Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000003991","article-title":"A multicenter prospective randomized controlled trial comparing cxbladder triage to cystoscopy in patients with microhematuria: the safe testing of risk for asymptomatic microhematuria trial","volume":"212","author":"Lotan Y","year":"2024","unstructured":"Lotan Y, Daneshmand S, Shore N, et al.. A multicenter prospective randomized controlled trial comparing cxbladder triage to cystoscopy in patients with microhematuria: the safe testing of risk for asymptomatic microhematuria trial. J Urol. 2024, 212:41-51. 10.1097\/JU.0000000000003991","journal-title":"J Urol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2020.09.001","article-title":"Validation of an mRNA-based urine test for the detection of bladder cancer in patients with haematuria","volume":"4","author":"Valenberg FJ","year":"2021","unstructured":"Valenberg FJ, Hiar AM, Wallace E, et al.. Validation of an mRNA-based urine test for the detection of bladder cancer in patients with haematuria. Eur Urol Oncol. 2021, 4:93-101. 10.1016\/j.euo.2020.09.001","journal-title":"Eur Urol Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s11192-009-0146-3","article-title":"Software survey: VOSviewer, a computer program for bibliometric mapping","volume":"84","author":"van Eck NJ","year":"2010","unstructured":"van Eck NJ, Waltman L. Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics. 2010, 84:523-38. 10.1007\/s11192-009-0146-3","journal-title":"Scientometrics"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-0134","article-title":"Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma","volume":"12","author":"Wang XS","year":"2006","unstructured":"Wang XS, Zhang Z, Wang HC, et al.. Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma. Clin Cancer Res. 2006, 12:4851-8. 10.1158\/1078-0432.CCR-06-0134","journal-title":"Clin Cancer Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.24390","article-title":"Identification of novel microRNA targets based on microRNA signatures in bladder cancer","volume":"125","author":"Ichimi T","year":"2009","unstructured":"Ichimi T, Enokida H, Okuno Y, et al.. Identification of novel microRNA targets based on microRNA signatures in bladder cancer. Int J Cancer. 2009, 125:345-52. 10.1002\/ijc.24390","journal-title":"Int J Cancer"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.02052","article-title":"Early detection of metastatic relapse and monitoring of therapeutic efficacy by ultra-deep sequencing of plasma cell-free DNA in patients with urothelial bladder carcinoma","volume":"37","author":"Christensen E","year":"2019","unstructured":"Christensen E, Birkenkamp-Demtr\u00f6der K, Sethi H, et al.. Early detection of metastatic relapse and monitoring of therapeutic efficacy by ultra-deep sequencing of plasma cell-free DNA in patients with urothelial bladder carcinoma. J Clin Oncol. 2019, 37:1547-57. 10.1200\/JCO.18.02052","journal-title":"J Clin Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(05)70315-6","article-title":"P53 as a prognostic marker for bladder cancer: a meta-analysis and review","volume":"6","author":"Malats N","year":"2005","unstructured":"Malats N, Bustos A, Nascimento CM, et al.. P53 as a prognostic marker for bladder cancer: a meta-analysis and review. Lancet Oncol. 2005, 6:678-86. 10.1016\/S1470-2045(05)70315-6","journal-title":"Lancet Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3310\/hta14040","article-title":"Systematic review of the clinical effectiveness and cost-effectiveness of photodynamic diagnosis and urine biomarkers (FISH, ImmunoCyt, NMP22) and cytology for the detection and follow-up of bladder cancer","volume":"14","author":"Mowatt G","year":"2010","unstructured":"Mowatt G, Zhu S, Kilonzo M, et al.. Systematic review of the clinical effectiveness and cost-effectiveness of photodynamic diagnosis and urine biomarkers (FISH, ImmunoCyt, NMP22) and cytology for the detection and follow-up of bladder cancer. Health Technol Assess. 2010, 14:1-331, iii-iv. 10.3310\/hta14040","journal-title":"Health Technol Assess"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2013.08.052","article-title":"Telomerase reverse transcriptase promoter mutations in bladder cancer: high frequency across stages, detection in urine, and lack of association with outcome","volume":"65","author":"Allory Y","year":"2014","unstructured":"Allory Y, Beukers W, Sagrera A, et al.. Telomerase reverse transcriptase promoter mutations in bladder cancer: high frequency across stages, detection in urine, and lack of association with outcome. Eur Urol. 2014, 65:360-6. 10.1016\/j.eururo.2013.08.052","journal-title":"Eur Urol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0100793","article-title":"Cell-free urinary microRNA-99a and microRNA-125b are diagnostic markers for the non-invasive screening of bladder cancer","volume":"9","author":"Zhang DZ","year":"2014","unstructured":"Zhang DZ, Lau KM, Chan ES, et al.. Cell-free urinary microRNA-99a and microRNA-125b are diagnostic markers for the non-invasive screening of bladder cancer. PLoS One. 2014, 9:e100793. 10.1371\/journal.pone.0100793","journal-title":"PLoS One"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2012.09.057","article-title":"ICUD-EAU international consultation on bladder cancer 2012: screening, diagnosis, and molecular markers","volume":"63","author":"Kamat AM","year":"2013","unstructured":"Kamat AM, Hegarty PK, Gee JR, et al.. ICUD-EAU international consultation on bladder cancer 2012: screening, diagnosis, and molecular markers. Eur Urol. 2013, 63:4-15. 10.1016\/j.eururo.2012.09.057","journal-title":"Eur Urol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2010.01816.x","article-title":"MiR-96 and miR-183 detection in urine serve as potential tumor markers of urothelial carcinoma: correlation with stage and grade, and comparison with urinary cytology","volume":"102","author":"Yamada Y","year":"2011","unstructured":"Yamada Y, Enokida H, Kojima S, et al.. MiR-96 and miR-183 detection in urine serve as potential tumor markers of urothelial carcinoma: correlation with stage and grade, and comparison with urinary cytology. Cancer Sci. 2011, 102:522-9. 10.1111\/j.1349-7006.2010.01816.x","journal-title":"Cancer Sci"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-0861","article-title":"A novel set of DNA methylation markers in urine sediments for sensitive\/specific detection of bladder cancer","volume":"13","author":"Yu J","year":"2007","unstructured":"Yu J, Zhu T, Wang Z, et al.. A novel set of DNA methylation markers in urine sediments for sensitive\/specific detection of bladder cancer. Clin Cancer Res. 2007, 13:7296-304. 10.1158\/1078-0432.CCR-07-0861","journal-title":"Clin Cancer Res"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.5489\/cuaj.600","article-title":"Biomarkers for detection and surveillance of bladder cancer","volume":"2","author":"Budman LI","year":"2008","unstructured":"Budman LI, Kassouf W, Steinberg JR. Biomarkers for detection and surveillance of bladder cancer. Can Urol Assoc J. 2008, 2:212-21. 10.5489\/cuaj.600","journal-title":"Can Urol Assoc J"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.21037\/tcr-20-1990","article-title":"Review of non-invasive urinary biomarkers in bladder cancer","volume":"9","author":"Lee HH","year":"2020","unstructured":"Lee HH, Kim SH. Review of non-invasive urinary biomarkers in bladder cancer. Transl Cancer Res. 2020, 9:6554-64. 10.21037\/tcr-20-1990","journal-title":"Transl Cancer Res"},{"key":"ref24","article-title":"Gontero P, Birtle A, Comp\u00e9rat E, et al.","author":"Gontero J","year":"2025","unstructured":"Gontero J, Birtle A, Comp\u00e9rat E, et al.. EAU Guidelines on Non-Muscle-Invasive Bladder Cancer (TaT1 and CIS). European Association of Urology, Arnhem, The Netherlands; 2025. https:\/\/d56bochluxqnz.cloudfront.net\/documents\/full-guideline\/EAU-Guidelines-on-Non-muscle-Invasive-BC-2025.pdf."},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000002135","article-title":"The diagnostic performance of cxbladder resolve, alone and in combination with other cxbladder tests, in the identification and priority evaluation of patients at risk for urothelial carcinoma","volume":"206","author":"Raman JD","year":"2021","unstructured":"Raman JD, Kavalieris L, Konety B, Porten S, Daneshmand S, Lotan Y, Loo R. The diagnostic performance of cxbladder resolve, alone and in combination with other cxbladder tests, in the identification and priority evaluation of patients at risk for urothelial carcinoma. J Urol. 2021, 206:1380-9. 10.1097\/JU.0000000000002135","journal-title":"J Urol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s13237-024-00494-2","article-title":"Advancements in bladder cancer detection: a comprehensive review on liquid biopsy and cell-free DNA analysis","author":"Rakshit I","year":"2024","unstructured":"Rakshit I, Mandal S, Pal S, Bhattacharjee P. Advancements in bladder cancer detection: a comprehensive review on liquid biopsy and cell-free DNA analysis. Nucleus. 2024, 10.1007\/s13237-024-00494-2","journal-title":"Nucleus"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2022.103577","article-title":"Liquid biopsy in bladder cancer: State of the art and future perspectives","volume":"170","author":"Crocetto F","year":"2022","unstructured":"Crocetto F, Barone B, Ferro M, et al.. Liquid biopsy in bladder cancer: State of the art and future perspectives. Crit Rev Oncol Hematol. 2022, 170:103577. 10.1016\/j.critrevonc.2022.103577","journal-title":"Crit Rev Oncol Hematol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/397254-global-research-trends-in-bladder-cancer-biomarkers-a-bibliometric-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T09:41:29Z","timestamp":1755855689000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/397254-global-research-trends-in-bladder-cancer-biomarkers-a-bibliometric-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,22]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.90724","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,22]]}}}